Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Hyalase for Carpal Tunnel Syndrome
NCT05280223Completed
- Sponsor
- Assiut University
- Start
- Apr 2022
- Primary completion
- Jun 2023
- Modality
- Therapeutic Enzymes, Small Molecules
- Countries
- 1
01
Overview
Randomised trial of dexmedetomidine and hyaluronidase in carpal tunnel syndrome (CTS), sponsored by Assiut University. Primary endpoint: Pain alleviation at 6 months. Started Apr 2022; status: completed.
02
Drugs
dexmedetomidinehyaluronidase
03
Conditions
carpal tunnel syndrome (CTS)
Beyond the preview
Go deeper on NCT05280223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05280223.